Previous studies [10,11,12] revealed that pathology-adenocarcinoma/adenosquamous cell carcinoma and high tumor marker CEA influence the clinical outcome in patients receiving radiation due to the radioresistant nature of tumors. This evidence concerns the gene CEACAM5 and adenosquamous carcinoma.